Showing results (211-220 of 1,630) with videos related to

Sort By:
Pageof 163
Expert Review of Clinical Pharmacology|June 30, 2021
A review of alternative intravenous acetylcysteine regimens for acetaminophen overdoseKevin Burnham, Tianrui Yang, Haleigh Smith, et al.
Expert Review of Clinical Pharmacology|January 8, 2021
Novel therapies for AML: a round-up for cliniciansMahesh Swaminathan, Eunice S Wang
Expert Review of Clinical Pharmacology|June 28, 2021
Effect of renal impairment on arsenic accumulation, methylation capacity, and safety in acute promyelocytic leukemia (APL) patients treated with arsenic trioxideQilei Zhao, Meihua Guo, Thomas H Hostetter, et al.
Expert Review of Clinical Pharmacology|February 28, 2020
Incidence and risk of proteinuria associated with newly approved vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: an up-to-date meta-analysis of randomized controlled trialsWei Zhang, Li-Jin Feng, Fei Teng, et al.
Expert Review of Clinical Pharmacology|March 3, 2020
The 'entourage effect' or 'hodge-podge hashish': the questionable rebranding, marketing, and expectations of cannabis polypharmacyPeter S Cogan
Expert Review of Clinical Pharmacology|April 5, 2020
A pharmacological profile of intravenous amisulpride for the treatment of postoperative nausea and vomitingGabriel Fox, Peter Kranke
Expert Review of Clinical Pharmacology|January 25, 2020
Pharmacodynamics of combined estrogen-progestin oral contraceptives: 4. Effects on uterine and cervical epitheliaCarlo Bastianelli, Manuela Farris, V Bruni, et al.
Expert Review of Clinical Pharmacology|December 4, 2019
Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathwaysKenneth Maiese
Expert Review of Clinical Pharmacology|September 1, 2020
Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlookPatrick C Gedeon, Cosette D Champion, Kristen E Rhodin, et al.
Expert Review of Clinical Pharmacology|January 27, 2021
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in SpainEsther Chamorro-de-Vega, Carmen-Guadalupe Rodriguez-Gonzalez, Silvia Manrique-Rodríguez, et al.
Pageof 163